Analytik Now Represent Microfluidics Corporation in the UK and Ireland
News Dec 16, 2014
Analytik has announced the representation of Microfluidics Corporation for the UK and Ireland market. Microfluidics, part of IDEX Corporation, is the manufacturer of unique high shear fluid processors, known as Microfluidizers, that can produce dispersions & emulsions of very tight particle size distributions, effectively de-agglomerate particles and disrupt cells in suspension.
Analytik has announced their partnership with Microfluidics Corporation (Westwood, MA, USA) for distribution and support of their Microfluidizer® fluid processors in the UK and Ireland. Microfluidics’ instruments are highly regarded in nano-enabled applications for uniform particle size reduction, cell disruption and bottom-up nanoparticle creation.
With scale-up guaranteed, it is not surprising that 17 of the top 20 global pharmaceutical companies have adopted Microfluidics’ technology for their processes among many companies in different industries.
Speaking about their new partnership, Analytik’s Product Specialist, James Anderson, provides background. “Microfluidics’ products complement our CPS Disc Centrifuge particle size analyzer that utilizes Differential Centrifugal Sedimentation (DCS). The CPS is one of the few instruments that can show the true results of any fluidic particle size reduction process. As such, it is ideal for proving Microfluidics’ performance advantages over the competition and allowing customers fine control over their particulate systems. This is particularly the case where solid particle dispersions are concerned.”
Continuing, James says “historically, Microfluidics is very strong in markets where scaling up from research and development to full-scale production is required; this transition is guaranteed by the operating principals of the instruments. The main markets are the pharma (emulsions, API suspensions), chemicals (pigments, nanoparticles), biotech (cell disruption) and food (emulsions) industries; and also academic/commercial research.”
From a product perspective looking at the benefits of the range, guaranteed scale-up is extremely important to users (the same interaction chambers are used from 1 ml to thousand litre batches).
Microfluidizers achieve the highest commercially available shear rate under a constant pressure profile. This results in the products having very consistent, repeatable and narrow particle size distributions.
Compared to other high shear technologies, less passes are required to achieve the same or better results, saving money through reduced energy consumption and faster processing.
3-D Printed Sugar Scaffolds Offer Sweet Solution for Tissue EngineeringNews
University of Illinois engineers built a 3-D printer that offers a sweet solution to making detailed structures that commercial 3-D printers can’t: Rather than a layer-upon-layer solid shell, it produces a delicate network of thin ribbons of hardened isomalt, the type of sugar alcohol used to make throat lozenges.READ MORE
3D Printer Developed That Can Create Complex Biological TissuesNews
A UCLA bioengineer has developed a technique that uses a specially adapted 3D printer to build therapeutic biomaterials from multiple materials. The advance could be a step toward on-demand printing of complex artificial tissues for use in transplants and other surgeries.READ MORE
Microfluidic Device Captures Extracellular Vesicles Shed by Brain TumorsNews
Because needle biopsies of brain tumors are invasive and difficult, bioengineers supported by the National Institute of Biomedical Imaging and Bioengineering (NIBIB) have developed micro-technologies that capture extracellular vesicles (EVs) released by the tumor.READ MORE